BACE1 and Alzheimer disease: Since adult Bace1 deletion in 5xFAD mice reduced epileptiform spiking, while AZD3293 treatment in adult AD mice increased spiking, we proceeded to investigate whether AZD3293 has an off-target effect by increasing neuronal excitability and enhanced synchronous firing.